• Call Us! 786.749.1221

  • NASDAQ: SMFL $2.35

Smart for Life Appoints Accomplished Finance and Capital Markets Executive Arthur S. Reynolds to Board of Directors

Smart for Life Appoints Accomplished Finance and Capital Markets Executive Arthur S. Reynolds to Board of Directors

Smart for Life Appoints Accomplished Finance and Capital Markets Executive Arthur S. Reynolds to Board of Directors 1920 1080 Smart for Life, Inc.

Miami, FL –October 21, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional supplements and foods worldwide, today announced that Arthur S. Reynolds has been appointed to the Company’s Board of Directors. Mr. Reynolds will serve on the Compensation and Audit Committees and has been appointed Chair of the Audit Committee.

Arthur S. Reynolds is an accomplished international financier bringing more than 35 years of capital markets and financial experience providing cross-border financial consulting services in Europe for clients principally located in the United States. He is the founder of Rexon Limited of London and New York where he has served as managing director. Mr. Reynolds was founder and managing partner of London-based Value Management & Research (UK) Limited. Mr. Reynolds was the founder and served as managing director of Ferghana Financial Services Limited. Prior thereto, Mr. Reynolds held executive positions at Merrill Lynch International Bank Limited, Banque de la Société Financière Européene, J.P. Morgan & Company and Mobil Corporation. Mr. Reynolds previously served on the Board of Directors of ThermoEnergy Corporation, first as Chairman of the Audit Committee, subsequently as Chief Financial Officer, and finally as Chairman. Mr. Reynolds is a member of the Board of the International Festival Society and serves as Chairman of the Elgar Society’s North America Branch. Mr. Reynolds holds an B.A. from Columbia University, a M.A. from Cambridge University, and an M.B.A. in Finance from New York University.

A.J. Cervantes, Jr., Chairman of Smart for Life, stated, “We are delighted to welcome Arthur to the Board of Directors, including his role as Chairman of the audit committee. He brings extensive financial and executive experience across multiple sectors, with particular strength in the international arena, which will be particularly valuable as we expand our global footprint. Having completed five material acquisitions in just the last year alone, and having recently announced our sixth planned acquisition, we are on track to achieve our goal of surpassing a $100 million revenue run rate within the next 12 months. Given our aggressive growth plans, we look forward to benefitting from Arthur’s knowledge, experience, and skills, as we realize the synergies and operating efficiencies across the acquired companies. We also believe his appointment further reflects our commitment to the highest levels of corporate governance.”

Mr. Reynolds further noted, “I am honored to join the Board of Smart for Life at this exciting time, especially given management’s proven track records and the highly fragmented nature of this industry. They have repeatedly demonstrated their ability to acquire complementary businesses at attractive valuations, while driving economies of scale through their state-of-the-art manufacturing facilities. As a result, Smart for Life is rapidly emerging as a leader in the $400 billion nutraceuticals industry, with an impressive array of high quality nutritional foods and supplements. I look forward to leveraging my capital markets and M&A experience to help maximize value for shareholders.”

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceutamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021